These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 23744571)

  • 1. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
    Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
    Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
    Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
    Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
    Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
    Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
    Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Seet RC; Zhang Y; Moore SA; Wijdicks EF; Rabinstein AA
    Stroke; 2011 Aug; 42(8):2333-5. PubMed ID: 21659639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
    Cappellari M; Turcato G; Forlivesi S; Zivelonghi C; Bovi P; Bonetti B; Toni D
    Stroke; 2018 Feb; 49(2):397-404. PubMed ID: 29311264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
    Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N
    Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after stroke thrombolysis in patients >80 years treated within 3 hours vs >3-4.5 hours.
    Ahmed N; Lees KR; Ringleb PA; Bladin C; Collas D; Toni D; Ford GA;
    Neurology; 2017 Oct; 89(15):1561-1568. PubMed ID: 28887377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.